Data / Form D filings / Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc.: Form D filings
Aptevo Therapeutics Inc., a pharmaceuticals company in Seattle, WA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on August 26, 2026, reports $3.5 million sold of a $3.5 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2401 4th Ave. Suite 1050, Seattle, WA, 98121
- Phone
- (206) 838-0500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1671584
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | New notice | $3,472,683 | $3,472,683 | 3 | Aug 12, 2026 | sec.gov | |
| Apr 18, 2025 | New notice | $2,100,004 | $2,100,004 | 11 | Apr 3, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jeffrey G Lamothe | Executive Officer, Director | |
| Marvin L White | Executive Officer, Director | |
| Daphne Taylor | Executive Officer | |
| John E Niederhuber | Director | |
| Daniel J Abdun-Nabi | Director | |
| Grady Grant III | Director | |
| Zsolt Harsanyi | Director | |
| Barbara Lopez Kunz | Director |
Every Form D from the week of Aug 24, 2026 · All recent filings in Washington · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aptevo Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.